Eton Pharmaceuticals, Inc. ETON Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 53.5%-6.6pp | 60%-6.5pp | 66.6%-0.8pp | 67.4%-19.8pp | |
| Efficiency | |||||
| Asset turnover | 1×+0.2× | 0.7×-0.4× | 1.1×+0.3× | 0.8×0.0× | |
| Liquidity | |||||
| Current ratio | 1.6×-0.5× | 2.1×+0.4× | 1.7×-1.4× | 3.1×-2.1× | |
| Leverage | |||||
| Debt-to-equity | 1.2×0.0× | 1.2×+0.9× | 0.4×-0.2× | 0.5×+0.1× | |
| Valuation | |||||
| Market capitalization | $930.79M+156% | $347.01M+209% | $112.38M+57.5% | $71.34M-32.4% | |
| Price / sales | 10.7×+3.2× | 8.9×+5.3× | 3.6×+0.2× | 3.4×-1.5× | |
| Price / book | 30.4×+15.5× | 14.2×+6.9× | 7.3×+1.8× | 5.5×-0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Eton Pharmaceuticals, Inc.'s profit margins?
- Eton Pharmaceuticals, Inc. (ETON) runs a 54.8% gross margin and a -15.1% operating margin, with a -9.5% net margin.
- Where do Eton Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
